Nicotine Suppresses TNF-${\alpha}$ Expression in Human Fetal Astrocyte through the Modulation of Nuclear Factor-${\kappa}B$ Activation

  • Son, Il-Hong (Department of Neurology, Sanbon Medical Center, Wonkwang University) ;
  • Park, Yong-Hoon (Inam Neuroscience Research Center, Sanbon Medical Center, Wonkwang University) ;
  • Yang, Hyun-Duk (Department of Neurology, Sanbon Medical Center, Wonkwang University) ;
  • Lee, Sung-Ik (Department of Neurology, Sanbon Medical Center, Wonkwang University) ;
  • Han, Sun-Jung (Department of Neurology, Sanbon Medical Center, Wonkwang University) ;
  • Lee, Jai-Kyoo (Department of Emergency Medicine, Sanbon Medical Center, Wonkwang University) ;
  • Ha, Dae-Ho (Department of Orthopedics Sanbon Medical Center, Wonkwang University) ;
  • Kang, Hyung-Won (Department of Oriental Neuropsychiatry, Sanbon Oriental Medical Center, Wonkwang University) ;
  • Park, Joo-Young (Department of Microbiology, Wonju College of Medicine, Yonsei University) ;
  • Lee, Sung-Soo (Department of Neurology, Wonju College of Medicine, Yonsei University)
  • Published : 2008.06.30

Abstract

Parkinson's disease (PD) progresses severely by a gradual loss of dopaminergic neurons in the substantia nigra (SN). Epidemiological studies showed that the incidences of PD were reduced by smoking of which the major component, nicotine might be neuroprotective. But the function of nicotine, which might suppress the incidences of PD, is still unknown. Fortunately, recently it was reported that a glial reaction and inflammatory processes might participate in a selective loss of dopaminergic neurons in the SN. The levels of tumour necrosis factor (TNF)-${\alpha}$ synthesised by astrocytes and microglia are elevated in striatum and cerebrospinal fluid (CSF) in PD. TNF-${\alpha}$ kills the cultured dopaminergic neurons through the apoptosis mechanism. TNF-${\alpha}$ release from glial cells may mediate progression of nigral degeneration in PD. Nicotine pretreatment considerably decreases microglial activation with significant reduction of TNF-${\alpha}$ mRNA expression and TNF-${\alpha}$ release induced by lipopholysaccharide (LPS) stimulation. Thus, this study was intended to explore the role of nicotine pretreatment to inhibit the expressions of TNF-${\alpha}$ mRNA in human fetal astrocytes (HFA) stimulated with IL-$1{\beta}$. The results are as follows: HFA were pretreated with 0.1, 1, and $10{\mu}g/mL$ of nicotine and then stimulated with IL-$1{\beta}$ (100 pg/mL) for 2h. The inhibitory effect of nicotine on expressions of TNF-${\alpha}$ mRNA in HFA with pretreated $0.1{\mu}g/mL$ of nicotine was first noted at 8hr, and the inhibitory effect was maximal at 12 h. The inhibitory effect at $1{\mu}g/mL$ of nicotine was inhibited maximal at 24 h. Cytotoxic effects of nicotine were noted above $10{\mu}g/mL$ of nicotine. Moreover, Nicotine at 0.1, 1 and $10{\mu}g/mL$concentrations significantly inhibited IL-$1{\beta}$-induced TF-${\kappa}B$ activation. Collectively, these results indicate that in activated HFA, nicotine may inhibit the expression of TNF-${\alpha}$ mRNA through the pathway which suppresses the NF-${\kappa}B$ activation. This study suggests that nicotine might be neuroprotective to dopaminergic neurons in the SN and reduce the incidences of PD.

Keywords

References

  1. Quik, M., Bordia, T. & O'Leary, K. Nicotinic receptors as CNS targets for Parkinson's disease. Biochem Pharmacol 74:1224-1234 (2007) https://doi.org/10.1016/j.bcp.2007.06.015
  2. Picciotto, M. R. & Zoli, M. Neuroprotection via nAChRs: the role of nAChRs in neurodegenerative disorders such as Alzheimer's and Parkinson's disease. Front Biosci 13:492-504 (2008) https://doi.org/10.2741/2695
  3. Park, H. J. et al. Neuroprotective effect of nicotine on dopaminergic neurons by anti-inflammatory action. Eur J Neuroscience 26:79-89 (2007) https://doi.org/10.1111/j.1460-9568.2007.05636.x
  4. CastanA, O. A., Herrera, A. J., Cano, J. & Machado, A. Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system. J Neurochem 70:1584-1592 (1998) https://doi.org/10.1046/j.1471-4159.1998.70041584.x
  5. Hunot, S. et al. Nuclear translocation of NF-${\kappa}$ B is increased in dopaminergic neurons of patients with Parkinson disease. Proc Natl Acad Sci 94:7531-7536 (1997)
  6. McNaught, K. S. & Jenner, P. Dysfunction of rat forebrain astrocytes in culture alters cytokine and neurotrophic factor release. Neurosci Lett 285:61-65 (2000) https://doi.org/10.1016/S0304-3940(00)00982-4
  7. Baldwin, A. S. Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 14:649-683 (1996) https://doi.org/10.1146/annurev.immunol.14.1.649
  8. Lee, S. S. et al. Characterization of the two genes differentially expressed during development in human fetal astrocytes. Yonsei Med J 44:1059-1068 (2003) https://doi.org/10.3349/ymj.2003.44.6.1059
  9. Winkler, M. K. & Beveniste, E. N. Transforming growth factor-beta inhibition of cytokine-induced vascular cell adhesion molecule-1 expression in human astrocytes. Glia 22:171-179 (1998) https://doi.org/10.1002/(SICI)1098-1136(199802)22:2<171::AID-GLIA8>3.0.CO;2-A
  10. Park, J. Y. et al. Establishment of a culture method and characterization for human fetal astrocytes. Kor J Virol 31:39-45 (2001)
  11. Yamamoto, T. et al. Kinetic characterization of the nitric oxide toxicity for PC12 cells: effect of half-life time of NO release. Eur J Pharmacol 397:25-33 (2000) https://doi.org/10.1016/S0014-2999(00)00244-2
  12. Duhamel-Clerin, E. et al. Cellular expression of an HMGCR promoter-CAT fusion gene in transgenic mouse brain: evidence for a developmental regulation in oligodendrocytes. Glia 11:35-46 (1994) https://doi.org/10.1002/glia.440110106
  13. Hanaka, S., Abe, T., Itakura, H. & Matsumoto, A. Gene expression related to cholesterol metabolism in mouse brain during development. Brain Dev 22:321- 326 (2000) https://doi.org/10.1016/S0387-7604(00)00129-7
  14. Ghosh, S., May, M. J. & Kopp, E. B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16:225-260 (1998) https://doi.org/10.1146/annurev.immunol.16.1.225
  15. Giasson, B. I. & Lee, V. M. A new link between pesticides and Parkinson's disease. Nat Neurosci 3:1227-1228 (2000) https://doi.org/10.1038/81737
  16. De Simone, R., Ajmone-Cat, M. A., Carnevale, D. & Minghetti, L. Activation of alpha7 nicotinic acetylcholine receptor by nicotine selectively up-regulates cyclooxygenase-2 and prostaglandin E2 in rat microglial cultures. J Neuroinflammation 2:4 (2005) https://doi.org/10.1186/1742-2094-2-4
  17. Sugano, N., Shimada, K., Ito, K. & Murai, S. Nicotine inhibits the production of inflammatory mediators in U937 cells through modulation of nuclear factor-kappaB activation. Biochem Biophys Res Commun 252: 25-28 (1998) https://doi.org/10.1006/bbrc.1998.9599
  18. Yong, V. W. & Antel J. P. Culture of glial cells from human brain biopsies. In Biology and Pathology of Astrocyte-Neuron Interactions (ed. Fedoroff S.), pp. 271-281, Humana, New York (1992)